Active, not recruitingPhase 2NCT06899802
A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine
Studying Encephalitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Bavarian Nordic
- Principal Investigator
- Carlos A. Fierro, MDJohnson County Clin-Trials
- Intervention
- MVA-BN-WEV(biological)
- Enrollment
- 411 enrolled
- Eligibility
- 18-50 years · All sexes
- Timeline
- 2025 – 2027
Study locations (9)
- Benchmark Research, Sacramento, California, United States
- Lifeline Primary Care, Inc. / CCT Research, Lilburn, Georgia, United States
- Johnson County Clin-Trials, Lenexa, Kansas, United States
- Versailles Family Medicine, PLLC/CCT Research, Versailles, Kentucky, United States
- Benchmark Research, Kenner, Louisiana, United States
- Jefferson City Medical Group / Avacare, Jefferson City, Missouri, United States
- Clay-Platte Family Medicine, P.C./CCT Research, Kansas City, Missouri, United States
- Papillion Research Center/CCT Research, Papillion, Nebraska, United States
- Benchmark Research, San Angelo, Texas, United States
Collaborators
JPM CBRN Medical
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06899802 on ClinicalTrials.govOther trials for Encephalitis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07332234Optic Nerve Ultrasound for Assessing Cerebral Inflammation and Intracranial Hypertension in Cerebral PathologiesSpitalul Clinic de Boli Infecțioase și tropicale "Dr. Victor Babeș"
- ACTIVE NOT RECRUITINGNCT06820060Clinical Performance of QIAstat-Dx® Meningitis/Encephalitis (ME) Panel PlusQIAGEN Gaithersburg, Inc
- RECRUITINGPHASE1, PHASE2NCT06680128A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy AdultsSK Bioscience Co., Ltd.
- RECRUITINGNCT06368648CoMind Early Feasibility StudyCoMind Technologies Limited
- ACTIVE NOT RECRUITINGPHASE4NCT06678373Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence AreasLiaoning Chengda Biotechnology CO., LTD
- RECRUITINGPHASE2NCT06510426Early Interferon-beta Treatment for West-Nile Virus InfectionTel-Aviv Sourasky Medical Center
- RECRUITINGNCT07191223Evaluation of Knowledge on Tick-borne Encephalitis Virus (TBEV) Infection Among General Practitioners in FranceUniversity Hospital, Strasbourg, France
- RECRUITINGNCT07251049Acute Infectious Encephalitis and Myelitis in Guadeloupe by New Generation SequencingCentre Hospitalier Universitaire de la Guadeloupe